Benitec Biopharma Limited
BNTCW
BNTCW was delisted on the 14th of April, 2020.
1 hedge funds and large institutions have $4K invested in Benitec Biopharma Limited in 2019 Q4 according to their latest regulatory filings, with funds opening new positions, increasing their positions, 0 reducing their positions, and 1 closing their positions.
100% more capital invested
Capital invested by funds: $2K → $4K (+$2K)
50% less funds holding
Funds holding: 2 → 1 (-1)
100% less first-time investments, than exits
New positions opened: 0 | Existing positions closed: 1
Top Buyers
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SM
Sabby Management
Miami Beach,
Florida
|
-$1K |
BNTCW Hedge Fund Activity: Q4 2019 in Review
1 of the 5,076 institutional investors tracked by Wall St. Rank reported a position in Benitec Biopharma Limited (BNTCW) for Q4 2019, worth a combined $4K — up 100% from $2K a quarter earlier.
Sellers outnumbered buyers: 1 fund closed out of BNTCW and 0 opened new positions — a net loss of 1 holder — while 0 trimmed existing stakes and 0 added.
The largest seller was Sabby Management, exiting entirely with an estimated $1K sold.
- 1 institutional investor held Benitec Biopharma Limited (BNTCW) as of Q4 2019, down from 2 in Q3 2019.
- Funds reported $4K of Benitec Biopharma Limited stock for Q4 2019, up 100% quarter-over-quarter.
- 0 funds opened new Benitec Biopharma Limited positions in Q4 2019 and 1 closed out, a net change of -1 holder.
- The largest Benitec Biopharma Limited seller in Q4 2019 was Sabby Management, an estimated $1K sold.
Based on aggregated 13F filings for Q4 2019.